Suppr超能文献

一名乙肝患者的乙肝表面抗原、乙肝表面抗体、乙肝e抗原、乙肝e抗体及乙肝核心抗体均呈阳性:病例报告。

All-positive HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb in a patient with hepatitis B: A case report.

作者信息

Wang Fenfang, Zhang Qianchun, Zhang Ju, Yang Penghui, Pan Fei, Ren Xuefang, Yuan Hang, Chang Zhongbao

机构信息

Department of Clinical Immunology, Nanjing Kingmed Clinical Laboratory, Nanjing, Jiangsu, China.

Suqian Maternity Hospital, Suqian, Jiangsu, China.

出版信息

Medicine (Baltimore). 2025 Jan 10;104(2):e41197. doi: 10.1097/MD.0000000000041197.

Abstract

RATIONALE

Mass vaccination, low cost of immunoglobulins, and new drugs led to the emergence of new, unusual patterns of hepatitis B serum markers. This study reported a rare case of hepatitis B with all 5 positive serum markers, including HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb.

PATIENT CONCERNS

A 30-year-old female patient was admitted due to abnormal liver function. The 5 serum markers were all positive (+), including HBsAg, HBsAb, HBeAg, HBeAb, and HBcAb. After antiviral therapy, she was discharged with normal liver function and decreased hepatitis B virus-DNA levels, but all 5 serum markers were still positive. Regular follow-up was conducted every 3 months.

DIAGNOSES

Abnormal liver function.

INTERVENTIONS

The patient received antiviral treatment and liver protection therapy using entecavir dispersive tablet 0.5 mg po qd and glycyrrhizate diamine enteric capsule 150 mg po tid.

OUTCOMES

The patient's liver function was normal, hepatitis B virus-DNA continued to decline, and HBeAb turned negative at 6 months. After 9 and 12 months of follow-up, the results of hepatitis B markers in the patient were stable in HBsAg positive (+), HBeAb positive (+), and HBcAb positive (+).

LESSONS

The rare pattern of all 5 positive hepatitis B markers may occur in patients with chronic hepatitis B. Improvements can be achieved using first-line drugs and conventional treatment. Nevertheless, more attention should be paid to the patient's condition.

摘要

原理

大规模疫苗接种、免疫球蛋白低成本以及新药导致了乙型肝炎血清标志物出现新的、不寻常的模式。本研究报告了一例罕见的乙型肝炎病例,其血清五项标志物均呈阳性,包括乙肝表面抗原(HBsAg)、乙肝表面抗体(HBsAb)、乙肝e抗原(HBeAg)、乙肝e抗体(HBeAb)和乙肝核心抗体(HBcAb)。

患者情况

一名30岁女性患者因肝功能异常入院。血清五项标志物均为阳性(+),包括HBsAg、HBsAb、HBeAg、HBeAb和HBcAb。抗病毒治疗后,她肝功能恢复正常且乙肝病毒DNA水平下降而出院,但五项血清标志物仍为阳性。每3个月进行一次定期随访。

诊断

肝功能异常。

干预措施

患者接受抗病毒治疗及保肝治疗,口服恩替卡韦分散片0.5 mg,每日1次,以及甘草酸二铵肠溶胶囊150 mg,每日3次。

结果

患者肝功能正常,乙肝病毒DNA持续下降,6个月时HBeAb转阴。随访9个月和12个月后,患者乙肝标志物结果稳定在HBsAg阳性(+)、HBeAb阳性(+)和HBcAb阳性(+)。

经验教训

慢性乙型肝炎患者可能出现五项乙型肝炎标志物均为阳性的罕见模式。使用一线药物和常规治疗可取得改善。然而,仍应更加关注患者病情。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ccd/11731132/205457c0d691/medi-104-e41197-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验